top of page
Closeup of medical worker or pharmacist hands wearing blue latex protective gloves,pouring

Oral COVID-19 Treatment Study

For adults with active COVID infections

We are now enrolling for a clinical trial evaluating the effectiveness of an oral investigational medication for the treatment of COVID-19.

Eastside Research Associates has partnered with a sponsor who is researching the effectiveness of an investigational oral treatment for COVID-19 in reducing long-COVID and rebound COVID infections. Healthy adults who have tested positive within the last 5 days may qualify.

If you are interested in participating in this study or have questions about your eligibility, perform a self-check below and request a phone screen.

Participant Enrollment Criteria
  • 18-64 years of age

  • Confirmed positive COVID-19 infection within the last 5 days

  • BMI under 30

  • Not a current cigarette smoker (vaping or THC ok; past history of smoking OK)

  • No history of cardiovascular or lung disease

  • No diabetes

  • Not currently on dialysis

  • Additional criteria may apply 

Participants Will Receive
  • Receive access to study related medical equipment 

  • Receive compensation of $1,000+

Location and Time

  • All appointments are located at Eastside Research Associates in Redmond, WA

  • Study duration approximately 1 month

Join our patient list for future studies.

Please fill out the following form to join our patient list for current and future studies. A member of our study recruitment team will receive your information and reach out to you within one business day.

bottom of page